Orthopedic experts at Rush University Medical Center are the first in the Midwest to offer a new treatment using the first synthetic cartilage device approved by the FDA for patients suffering from painful arthritis at the base of the big toe.
Rush University Medical Center’s solid organ transplant program has better-than-expected rates of one-year adult patient survival after liver and kidney transplantation, according to the most recent transplantation report released by the Scientific Registry of Transplant Recipients (SRTR).
Dr. Alfonso Torquati, an internationally renowned expert in metabolic and weight loss surgery, is the new chairperson of the Department of General Surgery at Rush University Medical Center. Torquati assumed his new role Jan. 1.
Twenty-three physicians from Rush University Medical Center were named "top cancer doctors" in the January 2017 issue of Chicago magazine.
Rush University College of Nursing is ranked seventh among the 144 nursing schools listed in U.S. News & World Report's 2017 Best Online Nursing Programs list, improving four spots from the college’s 2016 online ranking.
Rush University students and staff will commemorate Martin Luther King Jr.’s birthday with a day of service Monday, Jan. 16.
The first study of its kind designed to test the effects of a diet on the decline of cognitive abilities among a large group of individuals 65 to 84 years who currently do not have cognitive impairment will begin in January.
Rush University Medical Center was awarded an $11.5 million grant by the National Institutes of Health to conduct a Phase II national clinical trial for children with fragile X syndrome. The promising drug therapy could potentially improve language learning in young children with fragile X syndrome compared to just speech/language therapy alone.
New research shows that a protein biomarker for chronic kidney disease originates in the bone marrow, an important step towards earlier detection and prevention of chronic kidney disease. Because immature myeloid cells appear as a main source of circulating suPAR protein, stem cell transplants may prove to be a viable approach to treat suPAR-associated kidney disease.
Dr. Shafiq Rab, with a public health background and innovative use of using mobile health care technology, is the new leader of Rush's information technology efforts